IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcinoma through the STAT3 pathway

被引:61
作者
Sun, Longhao [1 ,2 ]
Zhang, Xuebin [3 ]
Song, Qianqian [1 ]
Liu, Liang [1 ]
Forbes, Elizabeth [1 ]
Tian, Weijun [2 ]
Zhang, Zhixiang [2 ]
Kang, Ya'an [4 ]
Wang, Huamin [5 ]
Fleming, Jason B. [6 ]
Pasche, Boris C. [1 ]
Zhang, Wei [1 ]
机构
[1] Wake Forest Baptist Med Ctr, Dept Canc Biol, Comprehens Canc Ctr, Winston Salem, NC 27157 USA
[2] Tianjin Med Univ Gen Hosp, Dept Gen Surg, Tianjin 300052, Peoples R China
[3] Tianjin Huanhu Hosp, Dept Pathol, Tianjin 300350, Peoples R China
[4] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Anat Pathol, Houston, TX 77030 USA
[6] H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL 33612 USA
基金
美国国家卫生研究院; 中国国家自然科学基金;
关键词
IGFBP2; TAM; alternative polarization; PDAC; STAT3; FACTOR-BINDING PROTEIN-2; GROWTH-FACTOR; CANDIDATE BIOMARKER; THERAPEUTIC TARGET; DENDRITIC CELL; STELLATE CELLS; CANCER; INHIBITION; EXPRESSION; DIFFERENTIATION;
D O I
10.1016/j.canlet.2020.12.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor-associated macrophages (TAMs) represent the M2-like phenotype with potent immunosuppressive activity, and play a pro-tumor role in pancreatic ductal adenocarcinoma (PDAC) biology. In this study, we investigated the role of the insulin-like growth factor binding protein 2 (IGFBP2) as a determinant of TAM polarity. Clinical data revealed that the levels of IGFBP2 correlated with M2 TAMs accumulation and disease progression in human PDAC. In vivo mouse model experiments showed that IGFBP2 promoted an immunosuppressive microenvironment and tumor growth in a macrophage dependent manner. Bioinformatics analysis of PDAC transcriptomes revealed a significant association between IGFBP2 expression and M2 macrophage polarization and signal transducer and activator of transcription 3 (STAT3) activation. Mechanistic investigations demonstrated that IGFBP2 augmented the expression and secretion of IL-10 through STAT3 activation in PDAC cells, which induced TAM polarization toward an M2 phenotype. IGFBP2-polarized M2 macrophages significantly increased Tregs infiltration and impaired antitumor T-cell immunity in a mouse model. Thus, our investigations have illuminated the IGFBP2 signaling pathway that contributes to the macrophage-based immunosuppressive microenvironment in PDAC, suggesting that blocking the IGFBP2 axis constitutes a potential treatment strategy to reset TAM polarization toward an antitumor state in PDAC.
引用
收藏
页码:132 / 146
页数:15
相关论文
共 52 条
[11]   Receptor tyrosine kinases, not KRAS, activate PI3K in KRAS mutant colorectal cancers [J].
Ebi, Hiromichi ;
Corcoran, Ryan B. ;
Singh, Anurag ;
Chen, Zhao ;
Song, Youngchul ;
Lifshits, Eugene ;
Ryan, David P. ;
Meyerhardt, Jeffrey A. ;
Benes, Cyril ;
Settleman, Jeffrey ;
Cantley, Lewis C. ;
Wong, Kwok-Kin ;
Engelman, Jeffrey A. .
CANCER RESEARCH, 2011, 71
[12]   The Pancreas Cancer Microenvironment [J].
Feig, Christine ;
Gopinathan, Aarthi ;
Neesse, Albrecht ;
Chan, Derek S. ;
Cook, Natalie ;
Tuveson, David A. .
CLINICAL CANCER RESEARCH, 2012, 18 (16) :4266-4276
[13]   IGFBP2 Activates the NF-κB Pathway to Drive Epithelial-Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma [J].
Gao, Song ;
Sun, Yan ;
Zhang, Xuebin ;
Hu, Limei ;
Liu, Yuexin ;
Chua, Corrine Yingxuan ;
Phillips, Lynette M. ;
Ren, He ;
Fleming, Jason B. ;
Wang, Huamin ;
Chiao, Paul J. ;
Hao, Jihui ;
Zhang, Wei .
CANCER RESEARCH, 2016, 76 (22) :6543-6554
[14]   Cancer Microenvironment and Endoplasmic Reticulum Stress Response [J].
Giampietri, Claudia ;
Petrungaro, Simonetta ;
Conti, Silvia ;
Facchiano, Antonio ;
Filippini, Antonio ;
Ziparo, Elio .
MEDIATORS OF INFLAMMATION, 2015, 2015
[15]   Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB network [J].
Holmes, Kristen M. ;
Annala, Matti ;
Chua, Corrine Y. X. ;
Dunlap, Sarah M. ;
Liu, Yuexin ;
Hugen, Niek ;
Moore, Lynette M. ;
Cogdell, David ;
Hu, Limei ;
Nykter, Matti ;
Hess, Kenneth ;
Fuller, Gregory N. ;
Zhang, Wei .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (09) :3475-3480
[16]   Two-dimensional culture of human pancreatic adenocarcinoma cells results in an irreversible transition from epithelial to mesenchymal phenotype [J].
Kang, Ya'an ;
Zhang, Ran ;
Suzuki, Rei ;
Li, Shao-qiang ;
Rolfe, David ;
Truty, Mark J. ;
Chatterjees, Deyali ;
Thomas, Ryan M. ;
Cardwell, James ;
Wang, Yu ;
Wang, Huamin ;
Katz, Matthew H. ;
Fleming, Jason B. .
LABORATORY INVESTIGATION, 2015, 95 (02) :207-222
[17]   Downregulation of IGFBP2 is associated with resistance to IGF1R therapy in rhabdomyosarcoma [J].
Kang, Z. ;
Yu, Y. ;
Zhu, Y. J. ;
Davis, S. ;
Walker, R. ;
Meltzer, P. S. ;
Helman, L. J. ;
Cao, L. .
ONCOGENE, 2014, 33 (50) :5697-5705
[18]   Serum IGFBP2 and MSLN as diagnostic and prognostic biomarkers for pancreatic cancer [J].
Kendrick, Zachary W. ;
Firpo, Matthew A. ;
Repko, Robert C. ;
Scaife, Courtney L. ;
Adler, Douglas G. ;
Boucher, Kenneth M. ;
Mulvihill, Sean J. .
HPB, 2014, 16 (07) :670-676
[19]   Polarization of M2 macrophages requires Lamtor1 that integrates cytokine and amino-acid signals [J].
Kimura, Tetsuya ;
Nada, Shigeyuki ;
Takegahara, Noriko ;
Okuno, Tatsusada ;
Nojima, Satoshi ;
Kang, Sujin ;
Ito, Daisuke ;
Morimoto, Keiko ;
Hosokawa, Takashi ;
Hayama, Yoshitomo ;
Mitsui, Yuichi ;
Sakurai, Natsuki ;
Sarashina-Kida, Hana ;
Nishide, Masayuki ;
Maeda, Yohei ;
Takamatsu, Hyota ;
Okuzaki, Daisuke ;
Yamada, Masaki ;
Okada, Masato ;
Kumanogoh, Atsushi .
NATURE COMMUNICATIONS, 2016, 7
[20]   A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells [J].
Kong, Ling-Yuan ;
Abou-Ghazal, Mohamed K. ;
Wei, Jun ;
Chakraborty, Arup ;
Sun, Wei ;
Qiao, Wei ;
Fuller, Gregory N. ;
Fokt, Izabela ;
Grimm, Elizabeth A. ;
Schmittling, Robert J. ;
Archer, Gary E., Jr. ;
Sampson, John H. ;
Priebe, Waldemar ;
Heimberger, Amy B. .
CLINICAL CANCER RESEARCH, 2008, 14 (18) :5759-5768